Hira Mian
- Hematology top 5%
- Multiple Myeloma Research and Treatments 86
- Chronic Myeloid Leukemia Treatments 5
- Geriatrics and Gerontology top 5%
- Frailty in Older Adults 9
- Oncology top 10%
- Cancer Treatment and Pharmacology 26
- Peptidase Inhibition and Analysis 24
-
- Protein Degradation and Inhibitors 38
- Histone Deacetylase Inhibitors Research 6
-
- Health Systems, Economic Evaluations, Quality of Life 5
- Co-authors
- Tanya M. WildesMark A. FialaArleigh McCurdyGregory R. PondGhulam Rehman MohyuddinHsien SeowE.F. PaiNickolay Y. Chirgadze
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Hira Mian
93 papers receiving 655 citations
Peers
Comparison fields: 5 of 76
- Hematology 346
- Geriatrics and Gerontology 99
- Oncology 329
- Family Practice 16
- Endocrinology 27
Countries citing papers authored by Hira Mian
This map shows the geographic impact of Hira Mian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hira Mian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hira Mian more than expected).
Fields of papers citing papers by Hira Mian
This network shows the impact of papers produced by Hira Mian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hira Mian. The network helps show where Hira Mian may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hira Mian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 2 | |
| 8 | 2024 | 2 | |
| 9 | 2024 | 7 | |
| 10 | 2024 | 8 | |
| 11 | 2024 | 10 | |
| 12 | 2024 | 2 | |
| 13 | 2024 | 0 | |
| 14 | 2024 | 2 | |
| 15 | 2023 | 0 | |
| 16 | 2023 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2023 | 14 | |
| 19 | 2022 | 4 | |
| 20 | 2022 | 33 |
About Hira Mian
Hira Mian is a scholar working on Hematology, Geriatrics and Gerontology and Oncology, having authored 109 papers that have together received 668 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (86 papers), Protein Degradation and Inhibitors (38 papers), Cancer Treatment and Pharmacology (26 papers), Peptidase Inhibition and Analysis (24 papers), Frailty in Older Adults (9 papers), Histone Deacetylase Inhibitors Research (6 papers), Health Systems, Economic Evaluations, Quality of Life (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). The work is most often cited by research in Hematology (346 citations), Geriatrics and Gerontology (99 citations) and Oncology (329 citations). Hira Mian has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Tanya M. Wildes, Mark A. Fiala, Arleigh McCurdy, Gregory R. Pond, Ghulam Rehman Mohyuddin, Hsien Seow, E.F. Pai, Nickolay Y. Chirgadze, Rami Kotb and Martha Louzada. Their work appears in journals such as JAMA, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.